The first robust evidence shows that genetics significantly impacts the likelihood of developing myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). A large study identified eight regions of the human genome that differ between individuals with and without ME/CFS. Genetic variants in these regions raise the risk of developing the illness. Despite the findings, many people with these genetic variants do not develop ME/CFS. More research is crucial for developing diagnostic tests to identify those at high risk. The research enhances the legitimacy of ME/CFS in the medical community, emphasizing the need for further exploration into its causes and treatment.
The first robust evidence indicates that people's genes affect their likelihood of developing myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), with eight genomic regions identified.
Several variants of genes raise the risk of ME/CFS, but many individuals may carry these variants without ever developing the illness.
Prof Chris Ponting emphasized that genetics can significantly influence whether someone develops ME/CFS, highlighting ongoing research needs for diagnostic screenings.
This milestone research provides validity and credibility to ME patients, counteracting historical dismissals of the illness as 'not real'.
Collection
[
|
...
]